Banco Bilbao Vizcaya Argentaria, S.A. Gilead Sciences, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $10.9 Billion
- Q2 2025
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 566,262 shares of GILD stock, worth $67.6 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
566,262
Previous 564,533
0.31%
Holding current value
$67.6 Million
Previous $63.3 Million
0.75%
% of portfolio
0.58%
Previous 0.64%
Shares
23 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...